Evolving COVID-19 Pandemic in India: Why Addressing Chronic Diseases Today is even more Critical

  • Natasha Dawa Public Health Specialist, New Delhi, Delhi, India.
  • KR Thankappan Central University of Kerala, Kasaragod, Periya, India.
  • Jai Prakash Narain Former Director, WHO Regional Office for South-East Asia, New Delhi, Delhi, India.
Keywords: COVID-19, Pandemic, India


The COVID-19 pandemic is an unprecedented public health and developmental challenge never before experienced in our life-time. The clinical presentation ranges from asymptomatic infection to severe disease affecting various organs including pneumonia and death.


Ministry of Health and Family Welfare. Press information Bureau, Government of India. Posted On: : 08 June 2021. Avaialble from: https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1725229

World Health Organisation. The effects of virus variants on COVID-19 vaccines March 1, 2021. Available from: https://www.who.int/news-room/feature-stories/detail/the-effects-of-virus-variantson-covid-19-vaccines?gclid=EAIaIQobChMI5rO7ZDn7wIVj6uWCh3ThACUEAAYAiAAEgIlqvD_BwE

Narain JP. COVID-19 and chronic noncommunicable diseases: Profiling a deadly relationship. International Journal of Noncommunicable Diseases. 2020, Volume 5, Issue 2 Page 25-28. Available from: https://www.ijncd.org/article.asp?issn=2468-8827;year=2020;volume=5;issue=2;spage=25;epage=28;aulast=Narain

World Health Organisation. Global Health Observatory (GHO) Data. Available from: https://www.who.int/gho/ncd/mortality_morbidity/ncd_total_text/en/.

All India Press Trust of India. Aiming to Bring Down COVID-19 Mortality Rate Below 1%: Health Minister to MPs. September 17, 2020 8:38 pm IST. Available from: https://www.ndtv.com/india-news/coronavirusaiming-to-bring-down-covid-19-mortality-rate-below-1-health-minister-to-mps-2297114

Clark A, Jit M, Warren-Gash C, Guthrie B, H X Wang H, W Mercer S et al., Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study with the Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. Lancet Glob Health 2020;8: e1003–17, June 15, 2020. Available from: https://doi.org/10.1016/S2214-109X(20)30264-3

Gaur K, S. Khedar R, Mangal K, K. Sharma A , K. Dhamija R, Rajeev Gupta R. Macrolevel association of COVID-19 with non-communicable disease risk factors in India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 343e350 journal homepage: www.elsevier.com/locate/dsx. January 5, 2021

Kreutz R, Algharably EA, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, et al. Hypertension, the reninangiotensin system, and the risk of lower respiratory tract infections and lung injury: Implications for COVID-19. Cardiovasc Res 2020. doi: 10.1093/cvr/cvaa097. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184480/.

World Health Organization. The impact of the COVID-19 pandemic on non-communicable disease resources and services: results of a rapid assessment.2020

Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY) 2020; 12: 6049–57.